Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

BACKGROUND: Many current therapies for metastatic castration-resistant prostate cancer (mCRPC) are aimed at AR signaling; however, resistance to these therapies is inevitable. To personalize CRPC therapy in an individual with clinical progression despite maximal AR signaling blockade, it is importan...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Transl Med
Auteurs principaux: Reyes, Edwin E, VanderWeele, David J, Isikbay, Masis, Duggan, Ryan, Campanile, Alexa, Stadler, Walter M, Vander Griend, Donald J, Szmulewitz, Russell Z
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4252013/
https://ncbi.nlm.nih.gov/pubmed/25424879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0313-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires